Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The New Political Economy of PharmaceuticalsThe Healthcare System and the Pharmaceutical Industry in Indonesia

The New Political Economy of Pharmaceuticals: The Healthcare System and the Pharmaceutical... [Indonesia has experienced rapid economic and political change in the past decade. Its democratic transformation is of particular significance. Many analysts see Indonesia as the new BRIC (Brazil, Russia, India, China and South Africa) on the block.With a gross domestic product (GDP) growth rate of around 6.5 per cent in 2011, Indonesia is outstripping many other emerging markets (Economist, 2011). The majority of the population of around 238 million live in rural areas, with income dependent upon agriculture. In 2010 per capita income was estimated at US$4300. Both economic statistics and health indicators underscore how the country has surpassed the expectations of many development specialists (Bloom et al., 2011). While little is known about Indonesia’s healthcare system internationally, it is clear that economic development presents opportunities for better healthcare and growth in the pharmaceutical sector. This chapter provides a perspective on the Indonesian healthcare system and the development of its pharmaceutical industry in the post-Trade Related Aspects of Intellectual Property Rights (TRIPS) era.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

The New Political Economy of PharmaceuticalsThe Healthcare System and the Pharmaceutical Industry in Indonesia

Part of the International Political Economy Series Book Series
Editors: Löfgren, Hans; Williams, Owain David
Husada, Richard; Tjandrawinata, Raymond R.
The New Political Economy of Pharmaceuticals — Nov 6, 2015
Download PDF
17 pages

Loading next page...
 
/lp/springer-journals/the-new-political-economy-of-pharmaceuticals-the-healthcare-system-and-uAez1Gmj6q
Publisher
Palgrave Macmillan UK
Copyright
© Palgrave Macmillan, a division of Macmillan Publishers Limited 2013
ISBN
978-1-349-32976-2
Pages
134 –151
DOI
10.1057/9781137315854_7
Publisher site
See Chapter on Publisher Site

Abstract

[Indonesia has experienced rapid economic and political change in the past decade. Its democratic transformation is of particular significance. Many analysts see Indonesia as the new BRIC (Brazil, Russia, India, China and South Africa) on the block.With a gross domestic product (GDP) growth rate of around 6.5 per cent in 2011, Indonesia is outstripping many other emerging markets (Economist, 2011). The majority of the population of around 238 million live in rural areas, with income dependent upon agriculture. In 2010 per capita income was estimated at US$4300. Both economic statistics and health indicators underscore how the country has surpassed the expectations of many development specialists (Bloom et al., 2011). While little is known about Indonesia’s healthcare system internationally, it is clear that economic development presents opportunities for better healthcare and growth in the pharmaceutical sector. This chapter provides a perspective on the Indonesian healthcare system and the development of its pharmaceutical industry in the post-Trade Related Aspects of Intellectual Property Rights (TRIPS) era.]

Published: Nov 6, 2015

Keywords: Supply Chain; Gross Domestic Product; Intellectual Property; Generic Medicine; Good Manufacture Practice

There are no references for this article.